News
This issue of the CRS Newsletter contains a fascinating summary of five published articles that have some focus on animals as a source of compounds with the potential to treat human conditions or as models to facilitate understanding of disease and biological functions. Of particular interest are…
I jotted notes for this update as I flew back from the Partnership Opportunities for Drug Delivery (PODD) conference in Boston. CRS was well represented at this conference. The conference, now in its fourth year, was again chaired by Board of Scientific Advisors (BSA) member Barbara Lueckel.…
Samir Mitragotri is a prominent leader in the field of drug delivery and biomaterials. His contribution in the field of transdermal drug delivery was noticed by the community when his group successfully published the delivery of vaccines (proteins), insulin (peptides), and siRNA via skin into the…
Introduction
Ile-Pro-Pro (IPP) is a bioactive peptide found in bovine milk when casein is hydrolyzed by gastrointestinal enzymes. It has an angiotensin-converting enzyme inhibitory potency of 5µM with the potential to reduce blood pressure, if orally administered.1 Although IPP is stable in…
We are well into the new academic year and—for those of us in the Northern hemisphere—packing up all our memories from hopefully a wonderful summer.
Teaching is on my mind at this time, in particular an awareness of the increasing numbers of distance education programs and institutions offering…
Mauro Ferrari is the executive vice president of Houston Methodist Hospital (a U.S. News and World Report Honor Roll Hospital, 2016) and the president/CEO of the
Mauro Ferrari in front of the Houston Methodist Research Institute he inaugurated in 2011.Houston Methodist Research Institute, where he…
